alberto bravo-blas
Intima Bioscience
Cambridge, United Kingdom
Review Editor
Cancer Immunity and Immunotherapy
Intima Bioscience
Cambridge, United Kingdom
Review Editor
Cancer Immunity and Immunotherapy
Celyad SA
Mont-St-Guibert, Belgium
Review Editor
Cancer Immunity and Immunotherapy
San Raffaele Hospital (IRCCS)
Milan, Italy
Review Editor
Cancer Immunity and Immunotherapy
Texas Tech University Health Sciences Center
Lubbock, United States
Review Editor
Cancer Immunity and Immunotherapy
Centre for Cancer Biomarkers and Biotherapeutics, Barts Cancer Institute, Barts and The London School of Medicine and Dentistry, Queen Mary University of London
London, United Kingdom
Review Editor
Cancer Immunity and Immunotherapy
Université Catholique de Louvain
Louvain-la-Neuve, Belgium
Review Editor
Cancer Immunity and Immunotherapy
University Medical Center Göttingen
Göttingen, Germany
Review Editor
Cancer Immunity and Immunotherapy
Xcell Biosciences
San Francisco, United States
Review Editor
Cancer Immunity and Immunotherapy
The University of Queensland
Brisbane, Australia
Review Editor
Cancer Immunity and Immunotherapy
INSERM U1231 Lipides, Nutrition, Cancer (LNC)
Paris, France
Review Editor
Cancer Immunity and Immunotherapy
de Duve Institute, Faculté de pharmacie et des sciences biomédicales, Université catholique de Louvain
Brussels, Belgium
Review Editor
Cancer Immunity and Immunotherapy
University of Pittsburgh
Pittsburgh, United States
Review Editor
Cancer Immunity and Immunotherapy
Augusta University
Augusta, United States
Review Editor
Cancer Immunity and Immunotherapy
University Hospital rechts der Isar, Technical University of Munich
Munich, Germany
Review Editor
Cancer Immunity and Immunotherapy
School of Medicine, Emory University
Atlanta, United States
Review Editor
Cancer Immunity and Immunotherapy
BeiGene USA, Inc.
San Mateo, United States
Review Editor
Cancer Immunity and Immunotherapy